Fig. 7.
Mechanism of hyperprolactinemia in Covid-19: Prolactin (PRL) increases angiotensin II (AngII), IL-1β, IL-6, and arginine vasopressin (AVP) with reduction of dopa decarboxylase (DDC), with subsequent increase of PRL
Mechanism of hyperprolactinemia in Covid-19: Prolactin (PRL) increases angiotensin II (AngII), IL-1β, IL-6, and arginine vasopressin (AVP) with reduction of dopa decarboxylase (DDC), with subsequent increase of PRL